Choroidal neovascularization (CNV) represents a significant ophthalmologic condition characterized by the abnormal growth of blood vessels from the choroid layer beneath the retina. This pathological development poses a considerable threat to vision and has emerged as a critical focus area in retinal disease management. The Choroidal Neovascularization market is experiencing substantial evolution driven by advancing therapeutic innovations, improved diagnostic capabilities, and a growing understanding of disease mechanisms.
For further actions, you may consider blocking this person and/or reporting abuse
Top comments (0)